ESR1 and breast carcinoma: Studies in breast cancer are contradictory; higher HPGD expression has been reported in ERα-positive MCF-7 cell with reduced expression in ERα-negative MDA-MB-231 cells, where up-regulation was observed following treatment with demethylating agents [17].